EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stroke Clinician Interviews the Co-Founders of Phagenesis

Stroke Clinician

Stroke Clinician · 26.06.2026

DOI: 10.59236/sc.v3i2.128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke Clinician, online erschienen am 26.06.2026. Verfasst von Stroke Clinician. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke Clinician recently had the opportunity to interview Drs. Shaheen Hamdy, Chief Scientific Officer and Conor Mulrooney, Chief Operating Officer of Phagenesis. Drs. Hamdy and Mulrooney co-founded Phagenesis, the company that designed and developed the novel Phagenyx System.® Phagenyx is approved for the treatment of neurogenic dysphagia using pharyngeal electrical stimulation.

Zitieren

APA

Clinician, S. (2026). Stroke Clinician Interviews the Co-Founders of Phagenesis. Stroke Clinician. https://doi.org/10.59236/sc.v3i2.128

Vancouver

Clinician S. Stroke Clinician Interviews the Co-Founders of Phagenesis. Stroke Clinician. 2026. doi:10.59236/sc.v3i2.128

BibTeX
@article{Clinician2026,
  author = {Clinician, Stroke},
  title = {Stroke Clinician Interviews the Co-Founders of Phagenesis},
  journal = {Stroke Clinician},
  year = {2026},
  doi = {10.59236/sc.v3i2.128}
}
Kostenlos starten →